Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Novo Nordisk and Eli Lilly Could Have a Big Rival in the GLP-1 Market in a Few Years
August 18, 2024
Tickers
LLY
NVO
RHHBY
Tags
Recent Press Releases
RHHBY
NVO
From
Motley Fool
Roche Misses Out On Weight-Loss Blockbuster Drug, Now Playing Catch-Up In Booming Market
August 16, 2024
Tickers
LLY
NEWS
NVO
RHHBY
Tags
Benzinga
LLY
NVO
From
Benzinga
Why Is Small-Cap Tempest Therapeutics Stock Trading Higher On Thursday?
August 15, 2024
Tickers
NEWS
RHHBY
TPST
Tags
Health Care
Biotech
Small Cap
From
Benzinga
Prediction: This Company Will Disrupt Eli Lilly and Novo Nordisk in the Weight Loss Market (Hint: It's Not Pfizer)
August 15, 2024
Tickers
LLY
NVO
RHHBY
Tags
Market News
Recent Press Releases
RHHBY
From
Motley Fool
Cancer-Focused Syros Pharmaceuticals Stops Mid-Stage Leukemia Combo Therapy Study, Cites Disappointing Unexpected Outcome
August 13, 2024
Tickers
ABBV
BMY
NEWS
RHHBY
Tags
Stories That Matter
Top Stories
Movers
From
Benzinga
Merck Stops Lung Cancer Study For Keytruda Combo Due To Ineffective Results, Side Effects
August 08, 2024
Tickers
MRK
NEWS
RHHBY
Tags
Benzinga
MRK
Market News
From
Benzinga
Here's Why Eli Lilly Stock Dropped 12% Last Month
August 08, 2024
Tickers
AMGN
LLY
NVO
PFE
Tags
Market News
LLY
VKTX
From
Motley Fool
Roche Considers Selling Cancer Data Specialist Flatiron Health Business, Highlights Challenges With Start-Up Acquisitions
August 07, 2024
Tickers
C
GOOG
GOOGL
NEWS
Tags
Health Care
AI Generated
Rumors
From
Benzinga
Bristol Myers Squibb Terminates Cancer Drug Development Program With Agenus
August 05, 2024
Tickers
AGEN
BMY
MRK
NEWS
Tags
MRK
Market News
Benzinga
From
Benzinga
Are Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now.
August 02, 2024
Tickers
ALT
LLY
NVO
PFE
Tags
Market News
PFE
VKTX
From
Motley Fool
Weight Loss Drug Stocks Just Took a Hit. Should You Buy the Stock That Caused It?
July 29, 2024
Tickers
LLY
NVO
RHHBY
Tags
RHHBY
Recent Press Releases
LLY
From
Motley Fool
Novo Nordisk's Stock Dips In Pre-Market Despite Winning UK's Approval Of Weight Loss Drug: What's Going On
July 24, 2024
Tickers
LLY
NEWS
NVO
PFE
Tags
Biotech
Health Care
wegovy
From
Benzinga
Look Out, Eli Lilly and Novo Nordisk: Could Roche Be the Obesity Drug Stock to Really Watch?
July 23, 2024
Tickers
LLY
NVO
RHHBY
Tags
LLY
NVO
Recent Press Releases
From
Motley Fool
Oral Weight Loss Drugs Vs. Injections - Pills Are Promising Yet Challenging Frontier
July 22, 2024
Tickers
LLY
NEWS
NVO
PFE
Tags
Briefs
News
weight loss drugs
From
Benzinga
This Big Pharma Could Become a Leading Weight-Loss Stock. Should You Buy It?
July 22, 2024
Tickers
RHHBY
Tags
RHHBY
Recent Press Releases
Market News
From
Motley Fool
Better Dark Horse Weight Loss Drug Stock: Pfizer vs. Roche
July 22, 2024
Tickers
PFE
RHHBY
Tags
Market News
RHHBY
PFE
From
Motley Fool
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
July 18, 2024
Tickers
AMGN
AZN
HRTS
LLY
Tags
Small Cap
Biotech
weight/loss
From
Benzinga
VIX Stages Double-Digit Spike As Risk Off Takes Over; Chipmakers Fail To Rebound, Weight Loss Giants Eli Lilly, Novo Tumble: What's Driving Markets Thursday?
July 18, 2024
Tickers
AA
ABT
ALK
BX
Tags
Federal Reserve
Economics
Bonds
From
Benzinga
Why Roche Stock Just Popped, but Eli Lilly and Novo Nordisk Dropped
July 17, 2024
Tickers
LLY
NVO
RHHBY
Tags
Market News
RHHBY
Recent Press Releases
From
Motley Fool
Pfizer And Roche Advance On Their Weight Loss Drug Journeys
July 17, 2024
Tickers
LLY
NEWS
NVO
PFE
Tags
General
RHHBY
News
From
Benzinga
Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?
July 17, 2024
Tickers
GPCR
LLY
NEWS
NVO
Tags
Large Cap
Biotech
Health Care
From
Benzinga
Roche Highlights Encouraging Data From Newly-Acquired Second Weight Loss Drug Candidate In Early-Stage Study
July 17, 2024
Tickers
NEWS
RHHBY
Tags
Weight Loss Drug
Stories That Matter
General
From
Benzinga
3 Small-Cap Stocks With Explosive 2X Growth Potential
July 08, 2024
Tickers
AMGN
BAYRY
CHPT
EXAI
Tags
RHHBY
VRDN
CHPT
From
InvestorPlace
Roche's New Immunotherapy Fails To Show Benefit Over Merck's Blockbuster Keytruda In Lung Cancer Patients
July 05, 2024
Tickers
MRK
NEWS
RHHBY
Tags
Market News
MRK
Benzinga
From
Benzinga
AbbVie/Genmab's Epkinly FDA Approval Is A Positive Step, Analyst Says Additional Expansion Opportunities Underway
June 27, 2024
Tickers
ABBV
BNTX
GMAB
JNJ
Tags
Stories That Matter
JNJ
Analyst Color
From
Benzinga
Supreme Court Backs Pharmaceutical Giants in Iraq Terrorism Funding Case
June 24, 2024
Tickers
AZN
GEHC
JNJ
NEWS
Tags
Benzinga
PFE
Market News
From
Benzinga
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
June 21, 2024
Tickers
AMGN
AZN
BMY
GILD
Tags
Stories That Matter
Ozempic
JNJ
From
Benzinga
Sarepta Therapeutics (SRPT) Stock Surges 30% on Giant FDA Boost
June 21, 2024
Tickers
RHHBY
SRPT
Tags
RHHBY
Market News
NASDAQ:SRPT,OTCMKTS:RHHBY
From
InvestorPlace
FDA Approves Expanded Use For Sarepta's Rare Muscular Dystrophy Gene Therapy
June 21, 2024
Tickers
NEWS
PFE
RGNX
RHHBY
Tags
Market News
Benzinga
FDA
From
Benzinga
Goldman Sachs Optimistic About Regenxbio's Gene Therapy Pipeline, Sees Over 160% Upside
June 07, 2024
Tickers
ABBV
FDMT
NEWS
REGN
Tags
FDMT
RHHBY
Movers
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.